These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1099 related items for PubMed ID: 20180658

  • 1. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
    Maghsoodi M, Sadeghpoor F.
    Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Preparation of microparticles of naproxen with Eudragit RS and talc by spherical crystallization technique.
    Maghsoodi M, Esfahani M.
    Pharm Dev Technol; 2009 Aug; 14(4):442-50. PubMed ID: 19235551
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation and enhancement of physical stability of semi-solid dispersions containing piroxicam into hard gelatin capsules.
    Karataş A, Bekmezci S.
    Acta Pol Pharm; 2013 Aug; 70(5):883-97. PubMed ID: 24147368
    [Abstract] [Full Text] [Related]

  • 10. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
    Jug M, Bećirević-Laćan M, Cetina-Cizmek B, Horvat M.
    Pharmazie; 2004 Sep; 59(9):686-91. PubMed ID: 15497750
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S, Ortega M, Ma C.
    Int J Pharm; 2005 Sep 14; 301(1-2):209-16. PubMed ID: 16046087
    [Abstract] [Full Text] [Related]

  • 15. Formation and characterization of solid dispersions of piroxicam and polyvinylpyrrolidone using spray drying and precipitation with compressed antisolvent.
    Wu K, Li J, Wang W, Winstead DA.
    J Pharm Sci; 2009 Jul 14; 98(7):2422-31. PubMed ID: 18972575
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H, Fussnegger B, Bodmeier R.
    Int J Pharm; 2010 May 10; 390(2):165-73. PubMed ID: 20132875
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.